title: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
authors.forename: Sidney C
authors.initials: SC
authors.lastname: Smith
authors.forename: Jerilyn
authors.initials: J
authors.lastname: Allen
authors.forename: Steven N
authors.initials: SN
authors.lastname: Blair
authors.forename: Robert O
authors.initials: RO
authors.lastname: Bonow
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Brass
authors.forename: Gregg C
authors.initials: GC
authors.lastname: Fonarow
authors.forename: Scott M
authors.initials: SM
authors.lastname: Grundy
authors.forename: Loren
authors.initials: L
authors.lastname: Hiratzka
authors.forename: Daniel
authors.initials: D
authors.lastname: Jones
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
authors.forename: Lori
authors.initials: L
authors.lastname: Mosca
authors.forename: Thomas
authors.initials: T
authors.lastname: Pearson
authors.forename: Marc A
authors.initials: MA
authors.lastname: Pfeffer
authors.forename: Kathryn A
authors.initials: KA
authors.lastname: Taubert
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D050197:Atherosclerosis / Q000150:complications / Q000628:therapy; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000150:complications / Q000628:therapy*; D003920:Diabetes Mellitus / Q000628:therapy; D050171:Dyslipidemias / Q000628:therapy; D015438:Health Behavior; D006401:Hematologic Agents / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007252:Influenza Vaccines; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D009043:Motor Activity; D009765:Obesity / Q000628:therapy; D016540:Smoking Cessation
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D006401:Hematologic Agents; D000960:Hypolipidemic Agents; D007252:Influenza Vaccines; D000451:Mineralocorticoid Receptor Antagonists